New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice

I. O-Sullivan, A. Chopra, Tae Sung Kim, S. Magnuson, M. T. Falduto, J. Huang, E. P. Cohen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study describes a new strategy for the identification of squamous carcinoma antigens tumor-associated antigens (TAA). The antigens were discovered by comparing microarrays of squamous carcinoma vaccines highly enriched for immunotherapeutic cells with non-enriched vaccines. The vaccines were prepared by transferring sheared genomic DNA fragments (25 kb) from KLN205 cells, a squamous carcinoma cell line (DBA/2 mouse origin (H-2d) into LM fibroblasts (C3H/He origin, H-2k). The transferred tumor DNA segments integrate spontaneously into the genome of the recipient cells, replicate as the cells divide and are expressed. As only a small proportion of the transfected cell population was expected to have incorporated DNA segments that included genes specifying TAA (the vast majority specify normal cellular constituents), a novel strategy was employed to enrich the vaccine for TAA-positive cells. Microarrays were used to compare genes expressed by enriched and non-enriched vaccines. Seventy-five genes were overexpressed in cells from the enriched vaccine. One, the gene for Cytochrome P450 (family 2, subfamily e, polypeptide 1) (Cyp2e1), was overexpressed in the enriched but not the non-enriched vaccine. A vaccine for squamous carcinoma was prepared by transfer of a 357 bp fragment of the gene for Cyp2e1 into the fibroblast cell line. Robust immunity, sufficient to result in indefinite survival, was induced in tumor-bearing mice immunized with cells transfected with this gene fragment.

Original languageEnglish
Pages (from-to)389-398
Number of pages10
JournalCancer Gene Therapy
Volume14
Issue number4
DOIs
Publication statusPublished - 2007 Apr 1

Fingerprint

Squamous Cell Carcinoma
Vaccines
Antigens
Neoplasms
Neoplasm Antigens
Genes
Therapeutics
DNA
Fibroblasts
Cell Line
Inbred DBA Mouse
Immunity
Genome
Peptides
Population

Keywords

  • Cyp2e1
  • DNA-based vaccine
  • Immunotherapy
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice. / O-Sullivan, I.; Chopra, A.; Kim, Tae Sung; Magnuson, S.; Falduto, M. T.; Huang, J.; Cohen, E. P.

In: Cancer Gene Therapy, Vol. 14, No. 4, 01.04.2007, p. 389-398.

Research output: Contribution to journalArticle

O-Sullivan, I. ; Chopra, A. ; Kim, Tae Sung ; Magnuson, S. ; Falduto, M. T. ; Huang, J. ; Cohen, E. P. / New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice. In: Cancer Gene Therapy. 2007 ; Vol. 14, No. 4. pp. 389-398.
@article{d2ab78e5b2e745e28cb0e2d1fb9ad747,
title = "New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice",
abstract = "This study describes a new strategy for the identification of squamous carcinoma antigens tumor-associated antigens (TAA). The antigens were discovered by comparing microarrays of squamous carcinoma vaccines highly enriched for immunotherapeutic cells with non-enriched vaccines. The vaccines were prepared by transferring sheared genomic DNA fragments (25 kb) from KLN205 cells, a squamous carcinoma cell line (DBA/2 mouse origin (H-2d) into LM fibroblasts (C3H/He origin, H-2k). The transferred tumor DNA segments integrate spontaneously into the genome of the recipient cells, replicate as the cells divide and are expressed. As only a small proportion of the transfected cell population was expected to have incorporated DNA segments that included genes specifying TAA (the vast majority specify normal cellular constituents), a novel strategy was employed to enrich the vaccine for TAA-positive cells. Microarrays were used to compare genes expressed by enriched and non-enriched vaccines. Seventy-five genes were overexpressed in cells from the enriched vaccine. One, the gene for Cytochrome P450 (family 2, subfamily e, polypeptide 1) (Cyp2e1), was overexpressed in the enriched but not the non-enriched vaccine. A vaccine for squamous carcinoma was prepared by transfer of a 357 bp fragment of the gene for Cyp2e1 into the fibroblast cell line. Robust immunity, sufficient to result in indefinite survival, was induced in tumor-bearing mice immunized with cells transfected with this gene fragment.",
keywords = "Cyp2e1, DNA-based vaccine, Immunotherapy, Squamous cell carcinoma",
author = "I. O-Sullivan and A. Chopra and Kim, {Tae Sung} and S. Magnuson and Falduto, {M. T.} and J. Huang and Cohen, {E. P.}",
year = "2007",
month = "4",
day = "1",
doi = "10.1038/sj.cgt.7701023",
language = "English",
volume = "14",
pages = "389--398",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice

AU - O-Sullivan, I.

AU - Chopra, A.

AU - Kim, Tae Sung

AU - Magnuson, S.

AU - Falduto, M. T.

AU - Huang, J.

AU - Cohen, E. P.

PY - 2007/4/1

Y1 - 2007/4/1

N2 - This study describes a new strategy for the identification of squamous carcinoma antigens tumor-associated antigens (TAA). The antigens were discovered by comparing microarrays of squamous carcinoma vaccines highly enriched for immunotherapeutic cells with non-enriched vaccines. The vaccines were prepared by transferring sheared genomic DNA fragments (25 kb) from KLN205 cells, a squamous carcinoma cell line (DBA/2 mouse origin (H-2d) into LM fibroblasts (C3H/He origin, H-2k). The transferred tumor DNA segments integrate spontaneously into the genome of the recipient cells, replicate as the cells divide and are expressed. As only a small proportion of the transfected cell population was expected to have incorporated DNA segments that included genes specifying TAA (the vast majority specify normal cellular constituents), a novel strategy was employed to enrich the vaccine for TAA-positive cells. Microarrays were used to compare genes expressed by enriched and non-enriched vaccines. Seventy-five genes were overexpressed in cells from the enriched vaccine. One, the gene for Cytochrome P450 (family 2, subfamily e, polypeptide 1) (Cyp2e1), was overexpressed in the enriched but not the non-enriched vaccine. A vaccine for squamous carcinoma was prepared by transfer of a 357 bp fragment of the gene for Cyp2e1 into the fibroblast cell line. Robust immunity, sufficient to result in indefinite survival, was induced in tumor-bearing mice immunized with cells transfected with this gene fragment.

AB - This study describes a new strategy for the identification of squamous carcinoma antigens tumor-associated antigens (TAA). The antigens were discovered by comparing microarrays of squamous carcinoma vaccines highly enriched for immunotherapeutic cells with non-enriched vaccines. The vaccines were prepared by transferring sheared genomic DNA fragments (25 kb) from KLN205 cells, a squamous carcinoma cell line (DBA/2 mouse origin (H-2d) into LM fibroblasts (C3H/He origin, H-2k). The transferred tumor DNA segments integrate spontaneously into the genome of the recipient cells, replicate as the cells divide and are expressed. As only a small proportion of the transfected cell population was expected to have incorporated DNA segments that included genes specifying TAA (the vast majority specify normal cellular constituents), a novel strategy was employed to enrich the vaccine for TAA-positive cells. Microarrays were used to compare genes expressed by enriched and non-enriched vaccines. Seventy-five genes were overexpressed in cells from the enriched vaccine. One, the gene for Cytochrome P450 (family 2, subfamily e, polypeptide 1) (Cyp2e1), was overexpressed in the enriched but not the non-enriched vaccine. A vaccine for squamous carcinoma was prepared by transfer of a 357 bp fragment of the gene for Cyp2e1 into the fibroblast cell line. Robust immunity, sufficient to result in indefinite survival, was induced in tumor-bearing mice immunized with cells transfected with this gene fragment.

KW - Cyp2e1

KW - DNA-based vaccine

KW - Immunotherapy

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=33947238491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947238491&partnerID=8YFLogxK

U2 - 10.1038/sj.cgt.7701023

DO - 10.1038/sj.cgt.7701023

M3 - Article

C2 - 17273183

AN - SCOPUS:33947238491

VL - 14

SP - 389

EP - 398

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 4

ER -